As a part of a screening programme developed to evaluate the antimicrobial
activity of basidiomycetes, 317 isolates representing 204 species collected
in Spain were screened against a range of human clinical pathogens and lab
oratory controls. Extracts from 45% of the isolates, representing 109 speci
es, showed antimicrobial activity. Antibacterial activity was more pronounc
ed than antifungal activity. The proportion of extracts from basidiomycetes
showing antimicrobial activity was similar to or above that obtained for r
epresentative orders of Ascomycetes, such as Pezizales and Xylariales, but
lower than that produced by members of the orders Diaporthales, Eurotiales,
Hypocreales, Leotiales and Sordariales. Suprageneric taxa (orders and fami
lies) did not show pronounced differences in their antimicrobial activities
though such differences were observed at the genus level, suggesting that
the ability to produce these bioactive compounds is not homogenously distri
buted amongst the basidiomycetes. Isolates from some species showed large d
ifferences in their ability to produce metabolites with antimicrobial activ
ity, possibly reflecting genetic differences at the infraspecific level.